Terms: = Pancreatic cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Prognosis
3999 results:
1. Correlation between relative dose intensity of adjuvant S-1 chemotherapy and psoas muscle mass volume and survival after resection of pancreatic ductal adenocarcinoma: A retrospective study.
Sakamoto T; Kishino M; Murakami Y; Miyatani K; Hanaki T; Shishido Y; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Fujiwara Y
Medicine (Baltimore); 2024 May; 103(21):e38292. PubMed ID: 38788030
[TBL] [Abstract] [Full Text] [Related]
2. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma.
Fei H; Shi X; Sun D; Yang H; Wang D; Li K; Si X; Hu W
Sci Rep; 2024 May; 14(1):11790. PubMed ID: 38783033
[TBL] [Abstract] [Full Text] [Related]
3. The footprint of gut microbiota in gallbladder cancer: a mechanistic review.
Liu S; Li W; Chen J; Li M; Geng Y; Liu Y; Wu W
Front Cell Infect Microbiol; 2024; 14():1374238. PubMed ID: 38774627
[TBL] [Abstract] [Full Text] [Related]
4. Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.
Han F; Dong S; Chen Z; Dong C; Shi H; Du Y; Zhou W
Pak J Pharm Sci; 2024 Mar; 37(2):327-336. PubMed ID: 38767100
[TBL] [Abstract] [Full Text] [Related]
5. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract] [Full Text] [Related]
6. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
Zhang L; Li M; Sun QF; Yu HP
Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
[No Abstract] [Full Text] [Related]
8. Serum trace elements during treatment in pancreatic cancer patients and their associations with cancer prognosis.
Kim JA; Lee JK; Lee SY
Clin Nutr; 2024 Jun; 43(6):1459-1472. PubMed ID: 38714150
[TBL] [Abstract] [Full Text] [Related]
9. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
Sun L; Wang J; Li Y; Kang Y; Jiang Y; Zhang J; Qian S; Xu F
BMC Cancer; 2024 May; 24(1):567. PubMed ID: 38711020
[TBL] [Abstract] [Full Text] [Related]
10. Bilateral efforts to improve SERS detection efficiency of exosomes by Au/Na
Zhao Q; Cheng X; Hu S; Zhao M; Chen J; Mu M; Yang Y; Liu H; Hu L; Zhao B; Song W
Biosens Bioelectron; 2024 Aug; 258():116349. PubMed ID: 38705072
[TBL] [Abstract] [Full Text] [Related]
11. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
[TBL] [Abstract] [Full Text] [Related]
12. Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma.
Matsumoto T; Shiraki T; Niki M; Sato S; Tanaka G; Shimizu T; Yamaguchi T; Park KH; Mori S; Iso Y; Ishizuka M; Kubota K; Aoki T
Eur J Surg Oncol; 2024 Jun; 50(6):108356. PubMed ID: 38685177
[TBL] [Abstract] [Full Text] [Related]
13. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
14. Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study.
Zhang X; Zhu X; Zhong J; Zhao Y; Zhang X; Zhang W; Ye F; Yang C; Xue J; Xiong R; Wang J; Shen S; Pan Y; Li D; Song T; Bi X; Sun H; Xiang B; Gu S; Wen T; Lu S; Chen Y; Yin T; Liu L; Kuang M; Xu L; Li D; Cai J
Sci Rep; 2024 Apr; 14(1):9745. PubMed ID: 38679630
[TBL] [Abstract] [Full Text] [Related]
15. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma.
Tang H; Miao X; Yu C; Chai C; Su Y; Li L; Yi J; Ye Z; Miao L; Wang Z; Zhang H; Xu H; Zhou W
Sci Rep; 2024 Apr; 14(1):9259. PubMed ID: 38649719
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
[TBL] [Abstract] [Full Text] [Related]
17. Nuclear MAST4 Suppresses FOXO3 through Interaction with AKT3 and Induces Chemoresistance in pancreatic Ductal Carcinoma.
Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
[TBL] [Abstract] [Full Text] [Related]
18. Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks.
Cordeiro HG; Azevedo-Martins JM; Faria AVS; Rocha-Brito KJP; Milani R; Peppelenbosch M; Fuhler G; de Fátima Â; Ferreira-Halder CV
Cell Signal; 2024 Jul; 119():111174. PubMed ID: 38604340
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic impact of positive microscopic margins (R1 resection) in patients with GIST (gastrointestinal stromal tumours): Results of a multicenter European study.
Thibaut F; Veziant J; Warlaumont M; Gauthier V; Lefèvre J; Gronnier C; Bonnet S; Mabrut JY; Regimbeau JM; Benhaim L; Tiberio GAM; Mathonnet M; Regenet N; Chirica M; Glehen O; Mariani P; Panis Y; Genser L; Mutter D; Théreaux J; Bergeat D; Le Roy B; Brigand C; Eveno C; Guillaume P;
Eur J Surg Oncol; 2024 Jun; 50(6):108310. PubMed ID: 38598874
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
Zhou Y; Liu Z; Cheng Y; Li J; Fu W
J Gastrointest Surg; 2024 Apr; 28(4):559-565. PubMed ID: 38583910
[TBL] [Abstract] [Full Text] [Related]
[Next]
